Trung Son Pharma
Scope
Date
~
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Food & Beverage
Korea’s SPC Samlip, Siam Makro to tie up for Thai bakery business
SPC Samlip Corp., a unit of South Korea’s food and bakery giant SPC Group, said on Monday it has forged a business partnership with Siam Makro...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's Fexuclue safe to use with aspirin: Clinical trials
Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Novel medicines poised to be Korea’s next mainstay export
South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...
Feb 27, 2023 (Gmt+09:00)
-
Executive reshuffles
Hanwha accelerates generational shift with promotion of second son
South Korea’s chemicals-to-defense conglomerate Hanwha Group is accelerating its generational power shift by promoting the group chairman&rsqu...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma wins permission from Singapore for Nabota
South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota wins approval from Australia
Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
CMG Pharma acquires animal nutrition company ING Medix
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, said on Monday that it is moving into the pet nutrition supplement market by acquirin...
Jan 17, 2023 (Gmt+09:00)
-
ESG
Woori Financial wins MSCI ESG global leader rating for 2nd year
Woori Financial Group said on Thursday it has earned an AA rating for the second consecutive year in the global ESG rating announced by Morgan Stanl...
Dec 30, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Blockchain
Blockchain co. Reality Reflection's board to discuss mangement reshuffle
The South Korean blockchain ecosystem is facing a string of management disputes, hit by worsening conditions of the global cryptocurrency market.&nb...
Dec 05, 2022 (Gmt+09:00)
-
Construction
Hyundai Engineering completes Long Son plant project in Vietnam
South Korea’s Hyundai Engineering Co., the plant engineering and construction unit of Hyundai Motor Group, said Monday it has completed its co...
Nov 28, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Mezzion Pharma to try again for US FDA approval of drug
South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...
Nov 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics in CDO deal talks with global pharma firm
FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...
Nov 07, 2022 (Gmt+09:00)
-
Korean chipmakers
SoftBank’s Son expected to meet Samsung's Lee for Arm M&A discussion
SoftBank Group Corp. CEO Masayoshi Son, who also goes by the Korean name Son Jeong-ui, arrived in South Korea on Saturday. When asked about the purp...
Oct 02, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Samsung’s Lee, SoftBank’s Son to discuss partnership on ARM
Samsung Electronics Co. Vice Chairman Jay Y. Lee will meet with Japan’s SoftBank Group Chairman Masayoshi Son next month to discuss a deal reg...
Sep 22, 2022 (Gmt+09:00)
-
Leadership & Management
Hanwha's heir apparent promoted as group's vice chair
South Korea’s Hanwha Group promoted its petrochemical and energy unit Hanwha Solutions Corp. CEO Kim Dong Kwan as the group’s new vice c...
Aug 29, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
SoftBank Son's youngest brother poised to buy Korean VC arm
Taizo Son, the youngest brother of SoftBank Chairman Masayoshi Son, is poised to buy the group's South Korean venture capital arm for around 200 bil...
Aug 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Research & Development
Plagiarism scandal hits top S.Korean university over AI-themed papers
South Korea's most prestigious university is embroiled in a plagiarism scandal after two papers it published on artificial intelligence are believed...
Jul 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Food & Beverage
Paris Baguette enters Malaysia, eyes $2 trillion halal market
SPC Group’s bakery franchise Paris Baguette has chosen Malaysia as its eighth overseas market. The decision aligns with the food and beverage ...
Jun 20, 2022 (Gmt+09:00)
language -
Advertising & Marketing
Hana Financial scores big with Son Heung-min sports marketing
South Korea’s national soccer team, led by captain Son Heung-min, lost to Brazil 1-5 in a pre-World Cup friendly on Thursday, much to 65,000 K...
Jun 03, 2022 (Gmt+09:00)
-
IPOs
Korea’s tough IPO review drives bio startup to Nasdaq
A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...
Apr 22, 2022 (Gmt+09:00)
-
Bio & Pharma
Boryung takes 'health is wealth' to whole new level – space
South Korean biotech and pharmaceutical companies are expanding their footholds in the global space medicine market. Boryung, formerly Boryung Pharm...
Apr 20, 2022 (Gmt+09:00)
-
Pharmaceuticals
Samsung Bioepis to double biosimilars, may resume Nasdaq listing plans
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, plans to double the number of its biosimilar products on sale to 10 by 2025 and acce...
Feb 24, 2022 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet